We are live on
!
Find out more
KS
Karpas Strategies Portfolio holdings
AUM
$319M
1-Year Est. Return
14.42%
This Fund
S&P 500
This Quarter
Est. Return
+2.69%
1 Year Est. Return
+14.42%
3 Year Est. Return
+16.12%
5 Year Est. Return
+59.2%
10 Year Est. Return
+120.15%
AUM
$163M
AUM Growth
–
Cap. Flow
+$160M
Cap. Flow
% of AUM
98.24%
Top 10 Holdings %
Top 10 Hldgs %
38.47%
Holding
103
New
103
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$12M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$8.57M |
| 3 |
Merck
MRK
|
+$6.34M |
| 4 |
W.P. Carey
WPC
|
+$5.72M |
| 5 |
Brookfield
BN
|
+$5.61M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.48% |
| 2 | Energy | 19.05% |
| 3 | Healthcare | 14.69% |
| 4 | Real Estate | 9.19% |
| 5 | Communication Services | 7.5% |
Similar funds
RMC
GH
GFWEX
CCMLC
CU
LWMG
THWM
VFPI
Karpas Strategies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Karpas Strategies, which disclosed 103 positions worth $163M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Johnson & Johnson: 141,990 shares worth $12.2M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, followed by Energy and Healthcare.
- Karpas Strategies's largest Q2 2013 buy was Johnson & Johnson: 141,990 shares worth $12.2M.
- Karpas Strategies's ten largest holdings make up 38% of its $163M portfolio in Q2 2013.
- Karpas Strategies disclosed 103 positions in Q2 2013, its first 13F filing on record.
Based on Karpas Strategies's 13F filing for Q2 2013, filed 14 Aug 2013.